Immunosuppressive therapy
2025-2645
Unknown small_molecule active
Quick answer
Immunosuppressive therapy for In-stent Restenosis Lesion is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- In-stent Restenosis Lesion
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active